StockData
Immuron Ltd logo

Immuron Ltd (IMRN) stock

IMRNNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Sep 24, 2026Score 4/30
$0.87−0.03 (-3.20%)

Close on Nov 17, 2026Market cap $7.03MP/E –Yield –

Immuron price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Immuron's price to sales ratio was 1.3× on Nov 11, 2026, against 2.1× a year earlier. Over the last 5 years it ranged from 0.0× to 24.2×, with a median of 3.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.3×+0.4
2025Dec 31, 20250.9×−2.3
2024Dec 31, 20243.2×+3.2
2023Dec 29, 20230.0×−22.7
2022Dec 30, 202222.7×+11.2
2019Jul 31, 201911.6×−6.8
2018Dec 31, 201818.4×+8.7
2017Dec 29, 20179.7×−0.4
2016Dec 30, 201610.1×–

More Immuron figures

See a number that looks wrong?